According to sources in the Union Health Ministry, the Indian government has conducted a crackdown on pharmaceutical companies, resulting in the cancellation of licenses for 18 firms.
In a major crackdown on companies manufacturing spurious or substandard drugs, regulators on Tuesday either cancelled licenses of or halted manufacturing at 18 companies.
Permission to manufacture particular products was also cancelled for three companies, according to sources in the Union Health Ministry.
Showcause notices were issued to 26 companies after inspections by joint teams of central and state drug control offices.
The action came after the first phase of inspections at 76 companies across 20 states and Union Territories. The government has identified 203 companies based on reports of samples collected at random, it was informed.
More inspections will take place in the coming days, according to officials.
The appointment of Mass General Hospital obesity doctor Dr. Fatima Cody Stanford to the DGAC suggests that Biden’s big government is collaborating with billion-dollar Big Pharma to shape the new obesity policy.
You can read more about this topic here.